Phibro Animal Health Corp当前公司基本面数据相对稳定,最新ESG披露属于行业中等水平。增长潜力很大。当前估值合理,在药品行业排名30/159位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价43.00。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Phibro Animal Health Corp评分
相关信息
行业排名
30 / 159
全市场排名
103 / 4555
所属行业
药品
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
Phibro Animal Health Corp亮点
亮点风险
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
公司代码PAHC
公司Phibro Animal Health Corp
CEOBendheim (Jack C)
网址https://www.pahc.com/
常见问题
Phibro Animal Health Corp(PAHC)的当前股价是多少?
Phibro Animal Health Corp(PAHC)的当前股价是 40.060。
Phibro Animal Health Corp的股票代码是什么?
Phibro Animal Health Corp的股票代码是PAHC。
Phibro Animal Health Corp股票的52周最高点是多少?
Phibro Animal Health Corp股票的52周最高点是46.420。
Phibro Animal Health Corp股票的52周最低点是多少?
Phibro Animal Health Corp股票的52周最低点是16.160。
Phibro Animal Health Corp的市值是多少?
Phibro Animal Health Corp的市值是1.62B。
Phibro Animal Health Corp的净利润是多少?
Phibro Animal Health Corp的净利润为48.26M。
现在Phibro Animal Health Corp(PAHC)的股票是买入、持有还是卖出?
根据分析师评级,Phibro Animal Health Corp(PAHC)的总体评级为持有,目标价格为43.000。
Phibro Animal Health Corp(PAHC)股票的每股收益(EPS TTM)是多少
Phibro Animal Health Corp(PAHC)股票的每股收益(EPS TTM)是1.673。